CBX-12 is under clinical development by Cybrexa and currently in Phase II for Fallopian Tube Cancer. According to GlobalData, Phase II drugs for Fallopian Tube Cancer have a 41% phase transition ...

Consequently, NIPEP-TPPs enable the creation of peptide–drug conjugates (PDCs) that, depending on the targeting moiety, can be selectively delivered to almost any specific cell or tissue with hi ...

Antibody–drug conjugates have emerged as a powerful tool ... The drug linker is typically created as a peptide or carbohydrate that is cleaved inside the tumour cell after internalization ...

Ke Hou generated a compound that prevents tau aggregation in the murine brain, but the potential Alzheimer’s disease therapy ...

R&D Daily丨DaShi Pharmaceutical's first IND application for a new antibody drug targeting NGF was accepted ChK1 inhibitor!

INR:2922. crypto casino without kyc East Sunshine Pharmaceutical to win 1.5 billion antithrombotic drug Precision-guided myeloma drug! Melflufen, the fi ...

INR:9114. linkedin bet365 Unsaturated fatty acids can fight cancer? Cell sub-journal exclusively reveals the underlying mechanism of "ferroptosis" Precision-guide ...

INR:6016. counting cards online blackjack reddit Pfizer/BioNTech submits EUA application for COVID-19 vaccine, what next? Melflufen, a firs ...

In recent years, several ADC drugs have achieved sales exceeding 1 billion USD, drawing significant market attention. This rise in ADC drug ...

INR:9130. delhi satta 2020 chart “First-in-class” peptide-drug conjugate receives accelerated approval from FDA eLife: Asthma may increase the risk of ...

INR:5743. kolkata ff goes babu Four-in-one blood pressure and lipid-lowering drug for stroke prevention and myocardial infarction shows potential JAMA Sub-Jo ...